retatrutide heart issues and LDL Cholesterol: How GLP-1 Medications Lower Dis – Revolution Health & Wellness Eli Lilly's next-gen obesity drug

The medications high effectiveness, however, may come with a tradeoff of more intense side effects, such as nausea, diarrhea, constipation and vomiting

Some individuals notice subtle changes, while others report minimal psychological effects beyond those directly attributable to weight loss

doi: 10.3945/an.115.008623

These differences explain why two people on identical protocols can have somewhat different timelines

Glycemic efficacy and safety of glucagon-like peptide-1 receptor agonist on top of sodium-glucose co-transporter-2 inhibitor treatment compared to sodium-glucose co-transporter-2 inhibitor alone: a systematic review and meta-analysis of randomized controlled trials